Home - Products - Others - GRK (GPCRK) - GRK5-IN-2

GRK5-IN-2

CAS No. 1642839-27-7

GRK5-IN-2( —— )

Catalog No. M28800 CAS No. 1642839-27-7

GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	68	Get Quote
10MG	110	Get Quote
25MG	222	Get Quote
50MG	357	Get Quote
100MG	530	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

GRK5-IN-2
Note

Research use only, not for human use.
Brief Description

GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
Description

GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

GRK (GPCRK)
Recptor

NPY Y2
Research Area

——
Indication

——

Chemical Information

CAS Number

1642839-27-7
Formula Weight

380.4
Molecular Formula

C20H20N4O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 62.5 mg/mL (164.30 mM)
SMILES

Cn1c(-c2ccco2)nc2c1cc(Nc(cc1OC)cc(OC)c1OC)nc2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Domin H, et al. Characterization of the Brain Penetrant Neuropeptide Y Y2 Receptor Antagonist SF-11. ACS Chem Neurosci. 2019;10(8):3454-3463.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

GRK6-IN-2

GRK6-IN-2 is a potent G protein-coupled receptor kinase 6 (GRK6) inhibitor with potential antitumor activity.GRK6-IN-2 has been studied in multiple myeloma.
CCG-224406

A highly selective and potent GRK2 (G protein-coupled receptor kinase 2) inhibitor with IC50 of 130 nM.
CCG-215022

CCG-215022 (CCG215022) is a potent and selective pan GRK inhibitor with IC50 of 0.15/0.38/3.9 uM for GRK2/5/1 respectively.

Sign In Join Free